NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News $317.20 +12.29 (+4.03%) As of 08/21/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABU alerts:Sign Up Key Stats Today's Range$306.27▼$329.2050-Day Range$184.63▼$341.5552-Week Range$66.60▼$341.93Volume466,051 shsAverage Volume584,084 shsMarket Capitalization$688.32 millionAssets Under Management$673.35 millionDividend Yield0.32%Net Expense Ratio0.96%Aggregate RatingModerate Buy ETF Overview The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.55%0.57%0.51%0.53%Other Expenses0.21%0.52%0.53%0.60%0.54%Total Expense0.96%0.76%0.75%0.75%0.73%Fee Waiver0.00%-0.85%-0.67%-0.77%-0.68%Net Expense0.96%0.58%0.63%0.57%0.60% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABU ETF News HeadlinesDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Reaches New 52-Week High - What's Next?August 20 at 4:00 AM | americanbankingnews.comLABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited BreakoutApril 27, 2026 | 247wallst.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.August 23 at 1:00 AM | Weiss Ratings (Ad)Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position NowApril 23, 2026 | 247wallst.comSPXL: Replacing SPY With 3x Leverage Proven To Yield Positive Long-Term ResultsMarch 25, 2026 | seekingalpha.comTriple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026January 16, 2026 | 247wallst.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $159.39 at the beginning of 2026. Since then, LABU stock has increased by 99.0% and is now trading at $317.20. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares's stock reverse split on Monday, December 4th 2023.The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Top institutional investors of Direxion Daily S&P Biotech Bull 3x Shares include Valued Retirements Inc. (0.07%) and Ramsey Quantitative Systems (0.01%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings171 Fund Statistics Assets Under Management$673.35 million Average Daily Volume$406.64 thousand Discount/Premium0.25% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume4,496 Put Options1,891 Call Options2,605 Short Interest459,821 shs Miscellaneous Outstanding Shares2,170,000Beta2.44 Creation Unit50,000 Creation Fee$250.00 10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report Top 10 LABU HoldingsGoldman Finl Sq Trsry Inst 506Holding Weight: 17.01%S&P Biotechnology Select Industry Index SwapHolding Weight: 11.55%Dreyfus Govt Cash Man InsHolding Weight: 10.67%S&P Biotechnology Select Industry Index SwapHolding Weight: 9.21%S&P Biotechnology Select Industry Index SwapHolding Weight: 6.32%S&P Biotechnology Select Industry Index SwapHolding Weight: 6.10%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 1.94%S&P Biotechnology Select Industry Index SwapHolding Weight: 1.49%Twist Bioscience (NASDAQ:TWST)Holding Weight: 1.03%Apogee Therapeutics (NASDAQ:APGE)Holding Weight: 0.99%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 8/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts